Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences | 2021

Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats.

 
 
 
 

Abstract


BACKGROUND AND OBJECTIVE\nSpinal cord injury (SCI) is a major disabling disorder for which no effective treatment has yet been found. Regenerative incapability of neuronal cells as well as the secondary mechanisms of injury are the major reasons behind this clinical frustration. Thus, here we fabricated an erythropoietin-chitosan/alginate (EPO-CH/AL) hydrogel and investigated its local therapeutic effects on the apoptotic and inflammatory indices of SCI secondary injury.\n\n\nMETHODS\nEPO-CH/AL hydrogels were fabricated by the ionic gelation method, and they were characterized using SEM and FTIR. In vitro drug release profile of EPO-CH/AL hydrogels was evaluated by UV-vis spectroscopy. Experimental SCI was inflicted in rats which were then treated with CH/AL hydrogels containing different doses of EPO (1000, 5000 and 10,000\xa0IU/kg). The relative expression of Bax and Bcl2 (apoptosis index) and active and inactive forms of NF-κB (inflammation index) were assessed using western blot. Total serum levels of TNF-α were also assessed with ELISA, and histopathological and immunohistochemistry studies were carried out to check the overall changes in the injured tissues.\n\n\nRESULTS\nIn vitro drug release test indicated that the EPO-CH/AL hydrogels had a sustained- and controlled-release profile for EPO under these conditions. All the fabricated hydrogels dramatically reduced the elevated inflammation and apoptosis indices of the SCI-inflicted rats (p\u2009≤\u20090.05). Nevertheless, only EPO-CH/AL hydrogel (1000\xa0IU/kg EPO) significantly improved the tissue repair and histopathological appearance of the spinal cord at the sites of injury.\n\n\nCONCLUSION\nBased on our findings, EPO-CH/AL hydrogel (1000\xa0IU/kg EPO) can effectively improve experimental SCI in rats via inhibiting apoptosis and inflammation. Further studies are warranted to elucidate the contributing role of the scaffold in the observed effects.

Volume None
Pages None
DOI 10.1007/s40199-021-00399-4
Language English
Journal Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Full Text